Belosalik lotion Solution for external use, 100 ml
Dosage:
0.05% + 2% x 100ml
0.05% + 2% x 20ml
Release form:
Liquid
Ointment
Solution
Spray
Category
Psoriasis
Scope of the drug
Leather
Release form
Solution
Manufacturer country
Croatia
Package quantity, pcs
one
Belosalik lotion rr d / nar.
approx.
bottle-dropper polyeth.
100ml No. 1
Name ENG
BELOSALIC LOTION
Clinical and pharmacological group
Drug with anti-inflammatory and keratolytic action for external use
ATX code
Betamethasone in combination with other drugs
Dosage
0.05% + 2% x 100ml
Structure
1 g of solution contains:
Active substances: betamethasone dipropionate - 640 mcg, which corresponds to the content of betamethasone - 500 mcg
salicylic acid - 20 mg.
Excipients: disodium edetate - 0.3 mg, hypromellose 4000 cps - 5 mg, sodium hydroxide - 5 mg, isopropanol - 392 mg, water - 577.06 mg.
Indications
Subacute and chronic dermatoses, sensitive to GCS therapy, and accompanied by hyperkeratosis and desquamation: Psoriasis.
Seborrhea.
Seborrheic dermatitis (scalp).
Asbestos lichen.
Neurodermatitis.
Lichen planus with localization on the scalp.
Eczema.
Dyshidrosis of the skin.
Ichthyosis.
INN / Active ingredient
salicylic acid, betamethasone
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
Contraindications
Skin tuberculosis, Skin manifestations of syphilis, Chickenpox, Viral infections of the skin, Skin post-vaccination reactions, Open wounds, Trophic ulcers, Rosacea, Acne vulgaris, Children up to 6 months of age, Hypersensitivity to betamethasone, salicylic acid or to any of the auxiliary components of the drug.
Specifications
Category
Psoriasis
Scope of the drug
Leather
Release form
Solution
Manufacturer country
Croatia
Package quantity, pcs
one
Scope of application
Dermatology
Minimum age from
6 months
Way of introduction
Locally
,
Outwardly
Vacation conditions
Without recipe
Volume, ml.
100 ml
Brand name
Belupo
The amount of the dosage form in the primary package
100 ml
Primary packaging type
Dropper bottle
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07XC01 Betamethasone, in combination with other drugs
Dosage form
Solution for external use
Packaging
Box
The target audience
Children
Expiration date in days
730
Package weight, g
120
Mode of application
:
The drug is intended for external use.
A few drops of solution for external use are evenly distributed over the surface of the skin, rubbing lightly.
Frequency rate of application - 2 times / day, in mild cases, a single use is sufficient.
The duration of a continuous course of treatment is usually limited to 3-4 weeks.
If a longer course of therapy is required, it is recommended to use the drug less often, for example, every other day.
The drug can be prescribed with caution to children from 6 months and for the shortest possible time.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + keratolytic agent
Dosage (volume) of the substance in the preparation
:
betamethasone dipropionate 640 mcg, which corresponds to the content of betamethasone 500 mcg, salicylic acid 20 mg